[Federal Register: May 12, 2004 (Volume 69, Number 92)]
[Notices]               
[Page 26408]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr12my04-70]                         


[[Page 26408]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 24, 2003, and published in the Federal 
Register on January 27, 2004, (69 FR 3946), Noramco, Inc., 500 Old 
Swedes Landing Road, Wilmington, Delaware 19801, made application by 
renewal to the Drug Enforcement Administration for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Morphone-N-Oxide (9307)....................  I
Codeine-N-Oxide (9053).....................  I
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Noramco, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Noramco, Inc. to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed is granted.

    Dated: April 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-10797 Filed 5-11-04; 8:45 am]

BILLING CODE 4410-09-M